CIK 0001400118 · <br>Emerging growth company
Sagimet Biosciences Inc.
Sign in to watch- Ticker
- SGMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205991472
- Phone
- (650) 561-8600
- Business address
- 950 TOWER LANE, STE 1500, FOSTER CITY, CA, 94404
- Former names
- 3-V Biosciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | Kemble George Director | Sale 10b5-1 | −350,987 | $10.23 | $3.6M | 62,161 |
| 2026-08-11 | Kemble George Director | Sale 10b5-1 | −20,206 | $9.95 | $201K | 62,161 |
| 2026-07-20 | Happel David President & CEO | Sale | −64,051 | $7.76 | $497K | 741,570 |
| 2026-07-20 | Rozek Elizabeth Chief Legal & Admin. Officer | Sale | −10,545 | $7.76 | $82K | 224,414 |
| 2026-07-20 | Kemble George Director | Sale 10b5-1 | −18,844 | $7.46 | $141K | 62,161 |
| 2026-02-10 | Happel David President & CEO | Sale | −12,101 | $5.36 | $65K | 677,621 |
| 2026-02-10 | Chauche Thierry Chief Financial Officer | Sale | −1,312 | $5.36 | $7K | 15,688 |
| 2026-02-10 | Martins Eduardo Bruno Chief Medical Officer | Sale | −3,640 | $5.36 | $20K | 103,296 |
| 2026-02-10 | Rozek Elizabeth Chief Legal & Admin. Officer | Sale | −2,622 | $5.36 | $14K | 190,959 |
| 2025-11-20 | Kemble George Executive Chairman | Sale 10b5-1 | −37,688 | $7.69 | $290K | 81,005 |
| 2025-07-21 | Happel David President & CEO | Sale | −65,478 | $9.13 | $598K | 689,722 |
| 2025-07-21 | Martins Eduardo Bruno Chief Medical Officer | Sale | −8,277 | $9.13 | $76K | 106,936 |
| 2025-07-21 | Rozek Elizabeth General Counsel and CCO | Sale | −10,780 | $9.13 | $98K | 183,726 |
| 2024-07-23 | Kemble George Executive Chairman | Sale 10b5-1 | −23,625 | $3.17 | $75K | 118,693 |
| 2024-07-19 | Martins Eduardo Bruno Chief Medical Officer | Sale | −8,357 | $3.10 | $26K | 81,213 |
| 2024-07-19 | Rozek Elizabeth General Counsel and CCO | Sale | −10,914 | $3.10 | $34K | 160,506 |
| 2024-07-19 | Kemble George Executive Chairman | Sale | −14,062 | $3.10 | $44K | 142,318 |
| 2023-07-18 | NEW ENTERPRISE ASSOCIATES 13 LP 10% owner | Sale | −662 | $16.00 | $11K | 3,820,275 |
Page 1 of 1 · 18 trades